Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IQV | Common Stock | Award | $0 | +24.1K | +122.52% | $0.00 | 43.8K | Feb 6, 2024 | Direct | F1 |
transaction | IQV | Common Stock | Tax liability | -$2.26M | -10.5K | -23.98% | $215.41 | 33.3K | Feb 6, 2024 | Direct | |
holding | IQV | Common Stock | 11.9K | Feb 6, 2024 | By Trust | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IQV | Stock Appreciation Right | Award | $0 | +20.7K | $0.00 | 20.7K | Feb 7, 2024 | Common Stock | 20.7K | $214.34 | Direct | F3 |
Id | Content |
---|---|
F1 | Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. |
F2 | Shares held in Ronald E. Bruehlman Revocable Trust. |
F3 | The stock appreciation right vests in three annual installments beginning on February 7, 2025. |
EVP & Chief Financial Officer